If your Part D plan does not cover B12 shots, you may request consideration under the plans utilization management program
Individuals with Gastrointestinal Disorders Conditions like Crohns disease or celiac disease can impair B12 absorption
What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes
(Product listing for a similar compounded B-complex injection
CPT 72275 (epidurography with interpretation) may be separately billable in limited circumstances when a full diagnostic epidurogram with formal interpretation is performed and documented as a distinct service from the therapeutic injection
The reduction in visceral fat, which is strongly associated with insulin resistance, provides additional metabolic benefits